Skip to main content
Premium Trial:

Request an Annual Quote

Queensland Bioinformatics Group to Use Ingenuity's Software

NEW YORK (GenomeWeb News) – The Queensland Facility for Advanced Bioinformatics (QFAB) will use Ingenuity Systems' life sciences analysis software in its biology, drug discovery, and translational medicine programs.

Ingenuity Systems said on Tuesday that QFAB will use the Ingenuity Pathway Analysis software through an agreement with Millenium Science, Ingenuity's Australia and New Zealand distributor.
QFAB's research is funded by the Australian Research Council in partnership with the Australian Stem Cell Centre and other partners.

The bioinformatics facility will use the IPA system to model and analyze high-throughput molecular data and curated data sets in medical, biotechnology, and environmental research.

Financial terms of the agreement were not released.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.